Helius Medical Technologies, Inc.

NasdaqCM:HSDT Stok Raporu

Piyasa değeri: US$1.8m

Helius Medical Technologies Gelecekteki Büyüme

Future kriter kontrolleri 2/6

Helius Medical Technologies's earnings are forecast to decline at 29.7% per annum while its annual revenue is expected to grow at 32.4% per year. EPS is expected to grow by 65.7% per annum.

Anahtar bilgiler

-29.7%

Kazanç büyüme oranı

65.7%

EPS büyüme oranı

Medical Equipment kazanç büyümesi17.4%
Gelir büyüme oranı32.4%
Gelecekteki özkaynak getirisin/a
Analist kapsamı

Low

Son güncelleme16 Oct 2024

Gelecekteki son büyüme güncellemeleri

Recent updates

Helius Medical Technologies: A Net-Net Meme Stock In The Making

Aug 23

Helius Medical Technologies stock slides 51% after pricing $18M securities offering

Aug 05

We Think Helius Medical Technologies (NASDAQ:HSDT) Needs To Drive Business Growth Carefully

Aug 18
We Think Helius Medical Technologies (NASDAQ:HSDT) Needs To Drive Business Growth Carefully

Helius Medical makes CEO, CFO appointments

Jun 15

Helius Medical Technologies announces reverse stock split

Dec 31

Helius Medical Technologies EPS beats by $0.01, beats on revenue

Nov 12

Kazanç ve Gelir Büyüme Tahminleri

NasdaqCM:HSDT - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (USD Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
12/31/20251-14N/AN/A1
12/31/20241-11N/AN/A1
6/30/20241-9-10-10N/A
3/31/20241-9-10-10N/A
12/31/20231-9-10-10N/A
9/30/20231-13-11-11N/A
6/30/20231-10-12-12N/A
3/31/20231-12-13-13N/A
12/31/20221-14-14-14N/A
9/30/20221-13-16-16N/A
6/30/20221-17-15-15N/A
3/31/20221-19-15-15N/A
12/31/20211-18-13-13N/A
9/30/20210-17-12-12N/A
6/30/20210-15-12-11N/A
3/31/20211-13-11-11N/A
12/31/20201-14-12-12N/A
9/30/20201-17-14-14N/A
6/30/20201-19-17-17N/A
3/31/20201-16-18-18N/A
12/31/20191-10-21-21N/A
9/30/20192-10-22-22N/A
6/30/20192-8-20-20N/A
3/31/20191-26-22-22N/A
12/31/20180-29-20-20N/A
9/30/2018N/A-27-20-20N/A
6/30/2018N/A-36-21-21N/A
3/31/2018N/A-24N/A-21N/A
12/31/2017N/A-28N/A-19N/A
9/30/2017N/A-30N/A-18N/A
6/30/2017N/A-20N/A-15N/A
3/31/2017N/A-18N/A-11N/A
12/31/2016N/A-16N/A-10N/A
9/30/2016N/A-12N/A-9N/A
6/30/2016N/A-7N/A-8N/A
3/31/2016N/A-7N/A-8N/A
12/31/2015N/A-5N/A-8N/A
9/30/2015N/A-5N/A-7N/A
6/30/2015N/A-11N/A-8N/A
3/31/2015N/A-10N/A-6N/A
12/31/2014N/A-8N/A-5N/A
9/30/2014N/A-6N/A-3N/A
6/30/2014N/A-3N/A-1N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: HSDT is forecast to remain unprofitable over the next 3 years.

Kazançlar ve Piyasa: HSDT is forecast to remain unprofitable over the next 3 years.

Yüksek Büyüme Kazançları: HSDT is forecast to remain unprofitable over the next 3 years.

Gelir ve Pazar: HSDT's revenue (32.4% per year) is forecast to grow faster than the US market (8.9% per year).

Yüksek Büyüme Geliri: HSDT's revenue (32.4% per year) is forecast to grow faster than 20% per year.


Hisse Başına Kazanç Büyüme Tahminleri


Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: Insufficient data to determine if HSDT's Return on Equity is forecast to be high in 3 years time


Büyüyen şirketleri keşfedin